Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma, Adult”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01908166
What this trial is testing

Ultrasound Elastography in Diagnosing Patients With Kidney or Liver Solid Focal Lesions

Who this might be right for
Adult Primary Liver CancerKidney Tumor
Stanford University 61
Testing effectiveness (Phase 2)Study completedNCT00941967
What this trial is testing

Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 78
Testing effectiveness (Phase 2)Looking for participantsNCT04770207
What this trial is testing

Intra-tumor Injection of Drug-eluting Microspheres With Multiple Drugs

Who this might be right for
Hepatocellular CarcinomaSolid Tumor, Adult
Second Affiliated Hospital of Guangzhou Medical University 100
Not applicableEnded earlyNCT01005875
What this trial is testing

Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
University of Alabama at Birmingham 5
Testing effectiveness (Phase 2)Study completedNCT00003907
What this trial is testing

Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver

Who this might be right for
Liver CancerMetastatic Cancer
Eastern Cooperative Oncology Group 50
Testing effectiveness (Phase 2)Study completedNCT00004108
What this trial is testing

DX-8951f in Treating Patients With Liver Cancer

Who this might be right for
Liver Cancer
Daiichi Sankyo
Testing effectiveness (Phase 2)Study completedNCT00875615
What this trial is testing

Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Liver Cancer
University of Miami 11
Testing effectiveness (Phase 2)Study completedNCT00483405
What this trial is testing

Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer

Who this might be right for
Liver Cancer
UNC Lineberger Comprehensive Cancer Center 33
Not applicableActive Not RecruitingNCT04390724
What this trial is testing

Optimizing Y90 Therapy for Radiation Lobectomy

Who this might be right for
HCCResectionTransplant+2 more
Northwestern University 104
Testing effectiveness (Phase 2)Study completedNCT00321594
What this trial is testing

Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07682454
What this trial is testing

Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin

Who this might be right for
Hepatocellular Carcinoma (HCC)Liver Cancer, Adult
University of California, San Francisco 50
Early research (Phase 1)Study completedNCT00049296
What this trial is testing

Thalidomide and Docetaxel in Treating Patients With Advanced Cancer

Who this might be right for
Cancer
Case Comprehensive Cancer Center 26
Not applicableEnded earlyNCT04315883
What this trial is testing

Yttrium-90 (TARE-Y90) in Children, Adolescents, and Young Adults With Liver Tumors

Who this might be right for
HepatoblastomaHepatocellular CarcinomaRhabdoid Tumor of Liver+3 more
Nemours Children's Clinic 3
Not applicableLooking for participantsNCT07070362
What this trial is testing

Digital Early Warning System for Acute Lung Injury in Liver Surgery

Who this might be right for
Acute Lung Injury(ALI)Liver CirrhosisARDS, Human+4 more
Beijing Tsinghua Chang Gung Hospital 3,000
Not applicableWithdrawnNCT03748927
What this trial is testing

Natural History Study of Children and Adults With Fibrolamellar Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatocellular Cancer
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00095992
What this trial is testing

SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer

Who this might be right for
Liver Cancer
NCIC Clinical Trials Group 15
Testing effectiveness (Phase 2)Ended earlyNCT05630937
What this trial is testing

Study on Safety and Efficacy of NMS-01940153E in Adult Patients With Unresectable Hepatocellular Carcinoma (HCC) Previously Treated With Systemic Therapy

Who this might be right for
Unresectable Hepatocellular Carcinoma (HCC)
Nerviano Medical Sciences 31
Testing effectiveness (Phase 2)WithdrawnNCT00039078
What this trial is testing

Radiolabeled Glass Beads (TheraSphere®) in Treating Patients With Primary Liver Cancer That Cannot Be Removed by Surgery

Who this might be right for
Liver Cancer
Allan Tsung
Testing effectiveness (Phase 2)Study completedNCT01835223
What this trial is testing

Tivozanib in Treating Patients With Liver Cancer That Is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Advanced Adult Hepatocellular CarcinomaNon-Resectable Hepatocellular Carcinoma
Roswell Park Cancer Institute 33
Early research (Phase 1)Ended earlyNCT00669136
What this trial is testing

Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaHepatomaLiver Cancer, Adult+11 more
Lisa H. Butterfield, Ph.D. 2
Next Page